| A Study of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60 to 85 Years in Stable Health (NCT03819049) | Janssen Research & Development, LLC | 2019-06-06 |
| Evaluate the Efficacy and Safety of ADCV01 As an Add-On Treatment for Primary Glioblastoma Multiforme (GBM) Patients (NCT04115761) | Ever Supreme Bio Technology Co., Ltd. | 2019-06-06 |
| Guadecitabine in Combination With Carboplatin in Extensive Stage Small Cell Lung Cancer (NCT03913455) | Shadia Jalal, MD | 2019-06-06 |
| A Trial to Assess Safety and Efficacy of ADO09 Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus (NCT03981627) | Adocia | 2019-06-06 |
| This Was a Dose-finding Study to Evaluate Efficacy and Safety of LOU064 in Patients With CSU Inadequately Controlled by H1-antihistamines (NCT03926611) | Novartis Pharmaceuticals | 2019-06-06 |
| Study of the Bioavailability of a Food Supplement Rich in Melatonin Administered Sublingually and Orally (MELATONIN) (NCT03951025) | Technological Centre of Nutrition and Health, Spain | 2019-06-05 |
| Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers (NCT03598309) | H. Lee Moffitt Cancer Center and Research Institute | 2019-06-05 |
| NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia Telangiectasia (NCT04870866) | University Hospital, Akershus | 2019-06-05 |
| Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy (NCT03719131) | Emory University | 2019-06-05 |
| Ramucirumab and Atezolizumab After Progression on Any Immune Checkpoint Blocker in NSCLC (NCT03689855) | Washington University School of Medicine | 2019-06-05 |
| Topical Sirolimus in Cutaneous Lymphatic Malformations (NCT03972592) | University Hospital, Tours | 2019-06-05 |
| Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma (NCT03513952) | National Cancer Institute (NCI) | 2019-06-05 |
| Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers (NCT03785210) | National Cancer Institute (NCI) | 2019-06-05 |
| Lopinavir/r/ Lamivudine/ Abacavir as an Easy to Use Paediatric Formulation (NCT03836833) | Drugs for Neglected Diseases | 2019-06-04 |
| A Study of MBG453 in Combination With Hypomethylating Agents in Subjects With IPSS-R Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS). (NCT03946670) | Novartis Pharmaceuticals | 2019-06-04 |
| Cabozantinib in Advanced Adrenocortical Carcinoma (NCT03612232) | Wuerzburg University Hospital | 2019-06-04 |
| An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer (NCT03915951) | Pfizer | 2019-06-04 |
| Firibastat or Ramipril After Acute Myocardial Infarction for Prevention of Left Ventricular Dysfunction (NCT03715998) | Quantum Genomics SA | 2019-06-04 |
| A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas (NCT03899805) | Dana-Farber Cancer Institute | 2019-06-04 |
| Vitamin D Supplementation in RNA-seq Profiles of Single-core Prostate Samples, Among Veterans (NCT04621500) | Medical University of South Carolina | 2019-06-04 |
| A Phase 1/2 Clinical Trial of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine (NCT04036526) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2019-06-04 |
| Apatinib Plus SHR1210 in Advanced Mucosal Melanoma (NCT03986515) | Henan Cancer Hospital | 2019-06-04 |
| Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal Adenocarcinoma (NCT03727880) | Lei Zheng | 2019-06-04 |
| Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) (NCT03977155) | Boston Pharmaceuticals | 2019-06-04 |
| Pharmacokinetics, Safety and Efficacy of BIA 5-1058 in PAH (Zamicastat) (NCT04316143) | Bial - Portela C S.A. | 2019-06-03 |
| Comparison of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® Ointment 0.1% in Treating Atopic Dermatitis (NCT03614221) | Chang Gung Memorial Hospital | 2019-06-03 |
| Efficacy of MVA-NP+M1 in the Influenza H3N2 Human Challenge Model (NCT03883113) | Barinthus Biotherapeutics | 2019-06-03 |
| Exploring the Theragnostic Value of Osimertinib in EGFR-mutated Lung Cancer (THEROS) (NCT03810066) | University Hospital, Essen | 2019-06-03 |
| Bacterial Decolonization to Prevent Radiation Dermatitis (NCT03883828) | Montefiore Medical Center | 2019-06-03 |
| A Clinical Study of Anetumab Ravtansine in Adults With Solid Tumors Who Have Been Treated in Previous Bayer-sponsored Anetumab Ravtansine Studies (NCT03926143) | Bayer | 2019-06-03 |
| Study of TQB2450 Combined With Anlotinib in the Treatment of Mutation Positive Lung Cancer (NCT03983928) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2019-06-03 |
| Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations (NCT03786796) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-06-03 |
| JAK Inhibitor Treatment in AGS (NCT03921554) | Adeline Vanderver, MD | 2019-06-03 |
| A Study Assessing the Safety, Tolerability, and Efficacy of Galegenimab (FHTR2163) in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD) (NCT03972709) | Genentech, Inc. | 2019-06-03 |
| Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition (NCT03926117) | Novo Nordisk A/S | 2019-06-03 |
| A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa (NCT03926169) | AbbVie | 2019-06-03 |
| Fasudil Eye Drop in Retinopathy Of Prematurity(ROP) (NCT04191954) | Shahid Beheshti University of Medical Sciences | 2019-06-02 |
| Sequential Treatment of Psoriasis With Integrated Traditional Chinese and Western Medicine (NCT03941431) | Shanghai Yueyang Integrated Medicine Hospital | 2019-06-01 |
| Palmitoylethanolamide Combined With Luteoline in Frontotemporal Dementia Patients. A Randomized Controlled Trial (NCT04489017) | I.R.C.C.S. Fondazione Santa Lucia | 2019-06-01 |
| ITT-5 Mechanisms of Spermatogenesis in Man (NCT02147964) | University of Washington | 2019-06-01 |
| RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer (NCT03894215) | Agenus Inc. | 2019-06-01 |
| Feasibility of FMISO in Brain Tumors (NCT03649880) | OHSU Knight Cancer Institute | 2019-06-01 |
| Comparing Lorcaserin Versus Duloxetine for the Treatment of Chemotherapy-Induced Peripheral Neuropathy (NCT03812523) | Southeastern Regional Medical Center | 2019-06-01 |
| Hand, Foot, and Mouth Disease: Could EPs®7630 be a Treatment Option (NCT06353477) | Eskisehir Osmangazi University | 2019-06-01 |
| Influence on Cough and Airway Symptoms by Oral Capsaicin (NCT04125563) | Vastra Gotaland Region | 2019-06-01 |
| Comparing Two Treatments That Both Target Smoking Cessation and Weight Loss at the Same Time. (NCT04130698) | Rhode Island College | 2019-06-01 |
| The Role of Optic Nerve Sheath Fenestration in Leukemic Patients Having Increased Intracranial Pressure (NCT04431882) | Alexandria University | 2019-06-01 |
| Recombinant Interleukin-7 (CYT107) to Restore Absolute Lymphocyte Counts in Sepsis Patients (NCT03821038) | Revimmune | 2019-06-01 |
| Trastuzumab in HER2-positive Biliary Tract Cancer (NCT03613168) | Changhoon Yoo | 2019-06-01 |
| Study of PD-1 Inhibitor Combination With Autologous Cell Immunotherapy in the Metastatic Renal Cell Carcinoma (NCT03987698) | Tianjin Medical University Cancer Institute and Hospital | 2019-06-01 |
| Pyrotinib Combined With Trastuzumab and AI in the First-line Treatment of HER2 Positive/ HR Positive MBC (NCT03910712) | Peking Union Medical College Hospital | 2019-06-01 |
| SHR-1210 Plus Apatinib in Patients With Advanced-Stage Hepatocellular Carcinoma (NCT04014101) | Shanghai Zhongshan Hospital | 2019-06-01 |
| Use of Ziv Aflibercept in Different Retinal Diseases (NCT04290195) | Amin El Sayed Nawar | 2019-06-01 |
| Oral Chinese Herbal Medicine for Psoriasis Vulgaris With Blood Stasis Syndrome (NCT03942198) | Shanghai Yueyang Integrated Medicine Hospital | 2019-06-01 |
| The Effect of Metformin on Breast Cancer Patients (NCT04559308) | Beni-Suef University | 2019-06-01 |
| A Phase 2 Study of IC14 in Acute Respiratory Distress Syndrome (NCT03017547) | Implicit Bioscience | 2019-06-01 |
| Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC) (NCT03869190) | Hoffmann-La Roche | 2019-06-01 |
| Study Of Intratumoral G100 In Cutaneous T Cell Lymphoma (NCT03742804) | Yale University | 2019-06-01 |
| Substance Misuse To Psychosis for Stimulants (NCT03485417) | The University of Hong Kong | 2019-06-01 |
| Inhaled Steroids for Acute Pharyngitis. (NCT04027322) | Oman Medical Speciality Board | 2019-06-01 |
| Supine Percutaneous Nephrolithotomy (NCT04869969) | Ain Shams University | 2019-06-01 |
| Allogeneic Donor Lymphocyte Infusions Combined With Blinatumomab (NCT03982992) | Ludwig-Maximilians - University of Munich | 2019-06-01 |
| Etoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 Type (NCT03963193) | Henan Cancer Hospital | 2019-06-01 |
| Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Fentanyl (NCT04136548) | University of Texas Southwestern Medical Center | 2019-06-01 |
| Endostar Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy for Locoregional Nasopharyngeal Carcinoma (NCT03932266) | Jiangsu Cancer Institute & Hospital | 2019-06-01 |
| Acceptability and Feasibility of Unsupervised HIV Self-Testing Among Networks of Men (NCT03891407) | University of South Carolina | 2019-06-01 |
| A Phase 2, 12-Week, Double-Blind, Efficacy and Safety of GX-G6 in Patients With Uncontrolled Type 2 Diabetes Mellitus (NCT03962010) | Genexine, Inc. | 2019-06-01 |
| Efficacy and Safety of Omega 3 Fatty Acid Supplements on Heavy Smokers (NCT03936621) | British Columbia Cancer Agency | 2019-06-01 |
| Rapid Determination Of The Clinical Utility Of Perampanel For The Treatment Of Alcohol Dependence (NCT02120365) | Virginia Commonwealth University | 2019-06-01 |
| The Effect of Platelet-rich Plasma in Subjects With Androgenetic Alopecia (NCT03048461) | Northwestern University | 2019-06-01 |
| Magnesium Supplementation in Diabetic Nephropathy (NCT03824379) | Ain Shams University | 2019-06-01 |
| A Proof of Concept Study With Rituximab in Patients With CIDP Not Responding to Conventional Immune Therapy (NCT05877040) | Istituto Clinico Humanitas | 2019-06-01 |
| Clinical Trial for Evaluating Efficacy and Safety of PDR001 in Concurrent Plus Consolidation Versus Consolidation Only in Addition to Standard Chemoradiotherapy in Unresectable Stage III NSCLC Patients (PASTURE) (NCT03945227) | Yonsei University | 2019-06-01 |
| Study of SHR-1210 Combined With Apatinib in the Treatment of Sarcoma (NCT04126993) | Tianjin Medical University Cancer Institute and Hospital | 2019-06-01 |
| The Effects of Sedatives on Tobacco Use Disorder (NCT03813121) | Wake Forest University Health Sciences | 2019-06-01 |
| Chinese Herbal Medicine for Psoriasis Vulgaris: a Real World Study (NCT03942185) | Shanghai Yueyang Integrated Medicine Hospital | 2019-06-01 |
| High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer (NCT03697239) | Hitendra Patel | 2019-06-01 |
| Novel Photosensitizer in The Treatment of Chronic Periodontitis (NCT04374383) | SVS Institute of Dental Sciences | 2019-06-01 |
| Anti-PD-1therapy Combined With Thermal Ablation for Advanced HCC (NCT03939975) | Sun Yat-sen University | 2019-06-01 |
| Paclitaxel Injection (Albumin-bound) for Neoadjuvant Treatment of Breast Cancer (NCT03959397) | Jilin University | 2019-06-01 |
| Exploratory Clinical Study of Apatinib and PD-1 in Treating Advanced Gastric Cancer (NCT03954756) | Henan Cancer Hospital | 2019-06-01 |
| Antimicrobial Synthetic Bone Grafts (NCT03945864) | Eskisehir Osmangazi University | 2019-06-01 |
| Apatinib Combined With Chemotherapy in the Treatment of Soft Tissue Sarcoma (NCT04126811) | Tianjin Medical University Cancer Institute and Hospital | 2019-06-01 |
| Double Blind Trial in Children With Autism Spectrum Disorder (NCT06058962) | Paxmedica | 2019-06-01 |
| Oral Chinese Herbal Medicine for Psoriasis Vulgaris With Blood Heat Syndrome (NCT03961230) | Shanghai Yueyang Integrated Medicine Hospital | 2019-06-01 |
| RESIST : Administration of MAP4343 in Antidepressant Non-Responders Patients Experiencing a Major Depressive Episode (NCT03870776) | Mapreg | 2019-06-01 |
| Anlotinib Neoadjuvant Treatment in Locally Advanced Thyroid Cancer (NCT04309136) | Fudan University | 2019-06-01 |
| Stem Cell Therapy and Growth Factor Ovarian in Vitro Activation (NCT04009473) | Forever Young d.o.o. | 2019-06-01 |
| Human Beta-2 Adrenergic Stimulation and Muscle Glucose Uptake (NCT03800290) | Maastricht University | 2019-06-01 |
| A Phase 2, Multicenter, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pefcalcitol Ointment, 0.005%, Applied Topically Twice Daily (BID) for 8 Weeks in Adolescent Subjects 12 to < 17 Years of Age With Plaque Psoriasis (NCT02970331) | Maruho Co., Ltd. | 2019-06-01 |
| Effect of Preemptive Intramuscular Diclofenac on Minimal Effective-Dose Bupivacaine Saddle Block for Minor Perianal Surgeries (NCT04849468) | Imam Abdulrahman Bin Faisal University | 2019-06-01 |
| Maintenance Of aNtiplatElet Therapy in Patients With Coronary Stenting Undergoing Surgery (MONET BRIDGE) (NCT03862651) | Ospedale Santa Croce-Carle Cuneo | 2019-06-01 |
| CD19+Targeted CAR-T Cell Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma (NCT04271410) | Chongqing Precision Biotech Co., Ltd | 2019-06-01 |
| Effect of Topical Sinonasal Antibiotics (NCT03935828) | United States Naval Medical Center, San Diego | 2019-06-01 |
| Cd133+ Cell Infusion in Patients With Colorectal Liver Metastases. (NCT03803241) | Hospital San Carlos, Madrid | 2019-05-31 |
| Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Participants With Chronic Hepatitis Delta (CHD) (NCT03852433) | Gilead Sciences | 2019-05-31 |
| Effectiveness of Sphenopalatine Ganglion Block for Post-Dural Puncture Headache (NCT03430531) | Milton S. Hershey Medical Center | 2019-05-31 |
| Safety and Efficacy of L19TNF in Patients With Isocitrate Dehydrogenase (IDH) Wildtype WHO Grade III / IV Glioma at First Relapse (NCT03779230) | Philogen S.p.A. | 2019-05-31 |
| A Study Lasmiditan (LY573144) in a Single Migraine Attack in Japanese Participants With Migraine (NCT03962738) | Eli Lilly and Company | 2019-05-31 |
| Safety and Efficacy of ARQ-151 Cream in Adolescents and Adults With Atopic Dermatitis (NCT03916081) | Arcutis Biotherapeutics, Inc. | 2019-05-31 |